Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaWillemijn J. Jansen, Helmut Hildebrandt, Rik Ossenkoppele et al.|JAMA|2015Cited by 1.6k
Prevalence of Amyloid PET Positivity in Dementia SyndromesRik Ossenkoppele, David J. Brooks, Gaël Chételat et al.|JAMA|2015Cited by 668
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Bernardino Ghetti, Eric McDade et al.|Annals of Neurology|2016Cited by 553
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J. Jansen, Lars Frings, Olin Janssen et al.|JAMA Neurology|2022Cited by 281
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Frank Jessen, Axel Rominger et al.|The Lancet Neurology|2013Cited by 185